Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
Opinion|Videos|June 12, 2024

Optimizing PAH Care Delivery for Better Outcomes

Following a review of strategies and care delivery models that could help optimize the management of PAH, Marius Hoeper, MD, discusses his recent publication on the long-term impact of sotatercept on morbidity and mortality.

Episodes in this series

Video content above is prompted by the following questions:

  • From a clinical perspective, what strategies or care delivery models could help optimize the management of pulmonary arterial hypertension (PAH) and potentially reduce the overall burden on the health care system while improving patient outcomes?
  • Discuss your recent publication on using a population health model to predict the long-term impact of the new PAH therapy sotatercept on morbidity and mortality. How can such modeling tools be leveraged by clinicians to better anticipate and plan for the clinical and economic effects of emerging PAH treatments?

Related Content